Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma

Clinical trial NCT07727993 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07727993
Sponsor: Ting Liu
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric or Gastroesophageal Junction Adenocarcinoma Propranolol SOX Chemotherapy Toripalimab

Start date: 2026-08-01
Primary completion: 2027-06-30
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.